- “Human Genome boosts biotech benchmark index” (MarketWatch)
- “FDA approves revised Erbitux colon cancer label” (The Associated Press)
- “International Conference on Alzheimer’s Disease (ICAD) Highlights Promise and Setbacks” (Press release issued by Cutting Edge Information, MarketWire)
- “FDA rejects Labopharm depression drug application” (Reuters)
- “US FDA staff: Medtronic heart valve study met goals” (Reuters)
- “Wyeth shareholders vote to be acquired by Pfizer” (The Associated Press)
- “Teva spent $1.8m on US lobbying in first half” (Globes)
- “Diprivan, the drug found in Michael Jackson’s home, may be more tightly restricted” (Chicago Tribune)
- “Drug Makers Criticized for Co-Pay Subsidies” (Wall Street Journal)
- “Boehringer’s HIV drug has edge over BMS’s Reyataz” (Reuters)
- “Roche says Xeloda combo works in colon cancer” (Reuters)
- “A bitter pill: Price of biologic drugs often too high for poor, ill seniors who need them” (NY Daily News)
- “Orexigen obesity drug meets goals in 3 studies” (The Associated Press)
- “GlaxoSmithKline: Benlysta Meets Primary Phase III Endpoints” (Wall Street Journal)
- “South Africa launches AIDS vaccine clinical trials” (The Associated Press)
THE LATEST WORD
Top Industry Stories – July 20, 2009
Posted on July 20th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
Careers | © 2009 Medical Dynamics